AR and prostate cancer: Transduction by an antibiotic-selectable AR-expression lentivirus allowed us then to derive a stable cell line, WPMY-AR, that expressed AR mRNA and protein at a level comparable to LNCaP cells that are often used to model a prostate cancer cells' response to androgens.